When was TriNetX founded?

TriNetX was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is TriNetX located?

TriNetX is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts.

Who is the current CEO of TriNetX?

Gadi Lachman of TriNetX. They have also founded 1 company.

How many employees does TriNetX have?

As of May 31, 2026, the latest employee count at TriNetX is 275.

Is TriNetX a funded company?

TriNetX is a funded company, having raised a total of $102M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 2014.

When was the latest funding round of TriNetX?

TriNetX's latest funding was a $***** Series D round on Mar 13, 2019, with participation from 6 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $2.19B in funding in 2026 to date.

Where does TriNetX rank among its competitors?

TriNetX ranks 9th amongst 304 active competitors, of which 55 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of TriNetX?

TriNetX's top competitors include Medidata, Verily and IQVIA. Among them, Verily secured the most recent funding round in March, 2026.

TriNetX - 2026 Company Profile, Team, Funding & Competitors

Company Details

TriNetX offers clinical trial management software for researchers and professionals. The company has developed tools like TriNetX Analyze that assist in analyzing clinical trial data, TriNetX Research that gives a comparative analysis of treatment and outcomes, TriNetX Analyze assist in analyzing medical reports for medication conflicts, and more. The TriNetX Network, allows researchers/sponsors to analyze patient populations, refine clinical study assumptions, and ultimately locate the best clinical sites and successfully recruit patients to their study. It enables pharmaceutical companies, healthcare providers, and CROs to truly leverage patient data in a way that fosters collaboration and efficiency in clinical research to make a lasting impact on drug development and bring new therapies to market faster.

Website: trinetx.com/
Social
Email ID: *****@trinetx.com
Phone Number: +1 **********
Registered Address: Cambridge, Massachusetts

Key Metrics

Founded Year

2013

Location

Cambridge, United States

Stage

Acquired

Total Funding

$102M in 2 rounds

Latest Funding Round

Series D, Mar 13, 2019, $*****

Investors

Merck Global Health Innovation Fund & 7 more

Ranked

9^th among 304 active competitors

Employee Count

275 as on May 31, 2026

Investment & Acquisitions

Advera Health & 1 more

Similar Companies

Medidata & 347 more

Exit Details

Acquired by The Carlyle Group (Sep 21, 2020)

View TriNetX's full profile

TriNetX is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TRINETX, INC CIN: 463329632 , United States, Active	Dec 31, 1999	-	162 (As on Dec 31, 2021)	-
TRINETX, LLC CIN: 853257141 , United States, Active	Dec 31, 1999	-	192 (As on Dec 31, 2024)	-
TRINETX, LLC CIN: 32081492756 , United States, Deadpooled	Oct 13, 2021	-	-	-

TriNetX got acquired by The Carlyle Group on Sep 21, 2020.

Click here to take a look at TriNetX's acquisition in detail

TriNetX has raised a total funding of $102M over 2 rounds. Its first funding round was on Jun 2014. Its latest funding round was a Series D round on Mar 13, 2019 for $*****. 6 investors participated in its latest round. TriNetX has 8 institutional investors.

Here is the list of recent funding rounds of TriNetX:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 13, 2019	2130140	Series D	6963007	1978242	6624789	2621988
Jun 2014	7630847	Series A	5786769	8698863	7815813	3348975

Access funding benchmarks and valuations. Sign up today!

View details of TriNetX's funding rounds and investors

The founders of TriNetX is Gadi Lachman. Gadi Lachman is the CEO of TriNetX.

Here are the details of TriNetX's key team members:

Gadi Lachman: Founder & CEO of TriNetX.

View details of TriNetX's Founder profiles and Board Members

TriNetX's employee count trend

TriNetX has 275 employees as of May 26. Here is TriNetX's employee count trend over the years:

Uncover TriNetX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TriNetX include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of TriNetX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	80/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	78/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
7th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, Tiger Global Management ... & 17 others	69/100
8th	Massive Bio 2014, New York City (United States), Series B	Provider of AI-based clinical trial management tool	$15.6M	Revo Capital, Philips HealthWorks & 8 others	67/100
9th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Deerfield, Mitsui & 6 others	66/100
10th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	Insight Partners, General Catalyst & 8 others	64/100